In last trading session, Silexion Therapeutics Corp (NASDAQ:SLXN) saw 0.31 million shares changing hands with its beta currently measuring 0.09. Company’s recent per share price level of $0.86 trading at -$0.08 or -8.22% at ring of the bell on the day assigns it a market valuation of $7.50M. That closing price of SLXN’s stock is at a discount of -14088.37% from its 52-week high price of $122.02 and is indicating a premium of 33.72% from its 52-week low price of $0.57. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.23 million shares which gives us an average trading volume of 14.06 million if we extend that period to 3-months.

Silexion Therapeutics Corp (NASDAQ:SLXN) trade information

Upright in the red during last session for losing -8.22%, in the last five days SLXN remained trading in the red while hitting it’s week-highest on Monday, 03/31/25 when the stock touched $0.86 price level, adding 24.9% to its value on the day. Silexion Therapeutics Corp’s shares saw a change of -57.08% in year-to-date performance and have moved -26.26% in past 5-day. Silexion Therapeutics Corp (NASDAQ:SLXN) showed a performance of -28.70% in past 30-days. Number of shares sold short was 0.42 million shares which calculate 0.04 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -286.10% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 96.36% while estimates for its earnings growth in next 5 years are of 59.98%.

Silexion Therapeutics Corp (NASDAQ:SLXN)’s Major holders

Insiders are in possession of 5.98% of company’s total shares while institution are holding 6.80 percent of that, with stock having share float percentage of 7.24%. Investors also watch the number of corporate investors in a company very closely, which is 6.80% institutions for Silexion Therapeutics Corp that are currently holding shares of the company.